SCHEMBL19086434

SCHEMBL19086434

COC(=O)C(Br)c1ccc(OC(=O)C(C)Br)cc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ELANE P08246 3/20 0.42
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 1/20 0.40
ESR1 P03372 1/20 0.39
HIF1A Q16665 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PTGS2 P35354 1/20 0.38
KMT2A Q03164 3/20 0.37
MEN1 O00255 1/20 0.37
RAB9A P51151 1/20 0.37
HPGD P15428 1/20 0.37
XBP1 P17861 1/20 0.37
HTT P42858 2/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
HSD17B10 Q99714 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.35
ATM Q13315 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1969461 0.85 LMNA (0.48) ELANEALDH1A1KDM4EESR1HIF1A
SCHEMBL3686069 0.84 ELANE (0.55) ELANEALDH1A1ESR1HIF1ASMN1; SMN2
SCHEMBL378101 0.82 KMT2A (0.49) ALDH1A1SMN1; SMN2KMT2AMEN1RAB9A
SCHEMBL4013745 0.81 KMT2A (0.49) ALDH1A1SMN1; SMN2KMT2AMEN1HPGD
SCHEMBL4013605 0.80 L3MBTL1 (0.46) ALDH1A1KDM4EESR1HIF1ASMN1; SMN2
SCHEMBL19470771 0.78 KMT2A (0.51) ALDH1A1ESR1HIF1ASMN1; SMN2KMT2A
SCHEMBL19086435 0.77 KMT2A (0.50) ALDH1A1ESR1HIF1ASMN1; SMN2KMT2A
SCHEMBL8881032 0.77 ESR1 (0.54) ALDH1A1ESR1KMT2ALMNAMAPT
SCHEMBL1564938 0.77 CYP1A2 (0.50) ALDH1A1SMN1; SMN2KMT2AMEN1RAB9A
SCHEMBL4776154 0.77 L3MBTL1 (0.45) ALDH1A1ESR1SMN1; SMN2KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3190131-B1 LIVING RADICAL POLYMERIZATION INITIATOR, METHOD FOR PRODUCING POLYMER, AND POLYMER UNIV KYOTO (JP) 2020-07-29 EP disclosed
US-10414848-B2 Living radical polymerization initiator, method for producing polymer, and polymer KYOTO UNIVERSITY (JP) 2019-09-17 US disclosed
US-20170306073-A1 LIVING RADICAL POLYMERIZATION INITIATOR, METHOD FOR PRODUCING POLYMER, AND POLYMER KYOTO UNIVERSITY (JP) 2017-10-26 US disclosed
EP-3190131-A1 LIVING RADICAL POLYMERIZATION INITIATOR, METHOD FOR PRODUCING POLYMER, AND POLYMER Kyoto University (JP) 2017-07-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10414848-B2 Living radical polymerization initiator, method for producing polymer, and polymer CCNY, MTR, PARN ELANE 2417/4885ALDH1A1 2596/4885KDM4E 241/4885
US-20170306073-A1 LIVING RADICAL POLYMERIZATION INITIATOR, METHOD FOR PRODUCING POLYMER, AND POLYMER CCNY, MTR, PARN ELANE 2417/4885ALDH1A1 2596/4885KDM4E 241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.